Pharsight

UCB PHARMA GMBH patents facing oppositions

Top patents of UCB PHARMA GMBH facing oppositions at the European Patent Office (EPO).

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP2645997B1 10 Aug, 2022 Once daily formulation of lacosamide Dec, 2031 1
EP2992891B1 05 Aug, 2020 Pharmaceutical composition comprising brivaracetam and lacosamide with synergistic anticonvulsant effect Jun, 2027 1
EP2037965B1 30 Aug, 2017 Pharmaceutical composition with synergistic anticonvulsant effect Jun, 2027 1